Personality Pathology and Functional Outcomes During Pharmacological Treatment of Adult ADHD
Personality and Mental Health · 2026-05 · 20 (2)
DOI: 10.1002/pmh.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Personality and Mental Health, online erschienen am 29.03.2026. Verfasst von Peter Jacobsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Sweden. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Personality Disorders, Central Nervous System Stimulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adults with ADHD show substantial variability in response to pharmacological treatment, and comorbid personality pathology may help explain why symptom improvement often fails to translate into meaningful functional improvement. This naturalistic longitudinal study examined whether dimensional personality pathology predicts symptomatic and functional outcomes during routine stimulant treatment. A total of 246 adults with ADHD (66% women; mean age = 33.5) contributed repeated assessments over irregular follow‐up intervals, with substantial attrition across waves. Linear mixed‐effects models were used to accommodate unbalanced repeated measures. Linear mixed‐effects models indicated that higher personality dysfunction was strongly associated with less improvement in functioning ( β = 0.44, p < 0.001) and more persistent ADHD symptoms ( β = 0.20, p < 0.001), independent of stimulant dose and time in treatment. Negative affectivity, detachment, psychoticism, and disinhibition were the maladaptive trait domains most consistently linked to poorer functional outcomes, whereas disinhibition showed the strongest association with residual ADHD symptom burden. Medication‐related effects were modest in comparison. These findings identify personality pathology as a clinically relevant source of heterogeneity in adult ADHD treatment response and support routine assessment of personality functioning to inform clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Sweden.
- Psychiatry Halland, Region Halland, Sweden.
- University of Zurich, Zurich, Switzerland.
- Department of Psychology, University of Minnesota, Minneapolis, Minnesota, USA.
- School of Public Health and Community Medicine, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Sweden.
- Centre for Ethics, Law and Mental Health (CELAM), Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Christopher J Hopwood, Robert F Krueger
Zitieren
APA
Jacobsson, P., Palage, E., Hopwood, C. J., Söderpalm, B., Krueger, R. F., Tasselius, V., & Nilsson, T. (2026). Personality Pathology and Functional Outcomes During Pharmacological Treatment of Adult ADHD. Personality and Mental Health, 20(2). https://doi.org/10.1002/pmh.70071
Vancouver
Jacobsson P, Palage E, Hopwood CJ, Söderpalm B, Krueger RF, Tasselius V, et al. Personality Pathology and Functional Outcomes During Pharmacological Treatment of Adult ADHD. Personality and Mental Health. 2026;20(2). doi:10.1002/pmh.70071
BibTeX
@article{Jacobsson2026,
author = {Jacobsson, Peter and Palage, Elin and Hopwood, Christopher J and Söderpalm, Bo and Krueger, Robert F and Tasselius, Viktor and Nilsson, Thomas},
title = {Personality Pathology and Functional Outcomes During Pharmacological Treatment of Adult ADHD},
journal = {Personality and Mental Health},
year = {2026},
volume = {20},
number = {2},
doi = {10.1002/pmh.70071}
}
EUVIMED